Robert Sergott

TitleProfessor
InstitutionThomas Jefferson University
DepartmentNeurosurgery
Address900 Walnut Street
Philadelphia PA 19107
Phone215-928-3130
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yeh EA, Giovannoni G, Hawkes C, Sergott RC, Levy M, Lechner-Scott J. OCT-Angiography in AQP4-positive NMOSD: finding subclinical disease using a new tool. Mult Scler Relat Disord. 2024 Mar 08; 84:105542. PMID: 38503246.
      Citations:    
    2. Covey TJ, Golan D, Sergott R, Wilken J, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Doniger GM, Penner IK, Hancock LM, Bogaardt H, Barrera MA, Morrow SA, Galetta S, Gudesblatt M. Peering further into the mind's eye: combining visual evoked potential and optical coherence tomography measures enhances insight into the variance in cognitive functioning in multiple sclerosis. J Neurol. 2023 Dec 13. PMID: 38091086.
      Citations:    
    3. Nieves-R?os C, Pulido JS, Thornton S, Dunn JP, Procopio RA, Oliver AL, Lee D, Edwards R, Sergott RC, Moster ML. Instances of ocular findings in transgender patients undergoing hormonal therapy. Am J Ophthalmol Case Rep. 2023 Dec; 32:101965. PMID: 38077787.
      Citations:    
    4. Procopio R, Pulido JS, Gunton KB, Syed ZA, Lee D, Moster ML, Sergott R, Neidich JA, Reynolds MM. Comparing Gene Panels for Non-Retinal Indications: A Systematic Review. Genes (Basel). 2023 Mar 17; 14(3). PMID: 36981008.
      Citations:    
    5. Bennett JL, Fujihara K, Kim HJ, Marignier R, O'Connor KC, Sergott RC, Traboulsee A, Wiendl H, Wuerfel J, Zamvil SS, Anania VG, Buffels R, K?nzel T, Lekkerkerker AN, Lennon-Chrimes S, Pittock SJ. SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab. Front Neurol. 2023; 14:1114667. PMID: 36873431.
      Citations:    
    6. Vignal-Clermont C, Yu-Wai-Man P, Newman NJ, Carelli V, Moster ML, Biousse V, Subramanian PS, Wang AG, Donahue SP, Leroy BP, Sadun AA, Klopstock T, Sergott RC, Fernandez R, Chwalisz BK, Banik R, Taiel M, Roux M, Sahel JA. Safety of Lenadogene Nolparvovec Gene Therapy Over 5 Years in 189 Patients With Leber Hereditary Optic Neuropathy. Am J Ophthalmol. 2022 Dec 08; 249:108-125. PMID: 36496192.
      Citations:    
    7. Carelli V, Newman NJ, Yu-Wai-Man P, Biousse V, Moster ML, Subramanian PS, Vignal-Clermont C, Wang AG, Donahue SP, Leroy BP, Sergott RC, Klopstock T, Sadun AA, Rebolleda Fern?ndez G, Chwalisz BK, Banik R, Girmens JF, La Morgia C, DeBusk AA, Jurkute N, Priglinger C, Karanjia R, Josse C, Salzmann J, Montestruc F, Roux M, Taiel M, Sahel JA. Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G>A MT-ND4 Mutation. Ophthalmol Ther. 2023 Feb; 12(1):401-429. PMID: 36449262.
      Citations:    
    8. Newman NJ, Yu-Wai-Man P, Subramanian PS, Moster ML, Wang AG, Donahue SP, Leroy BP, Carelli V, Biousse V, Vignal-Clermont C, Sergott RC, Sadun AA, Fern?ndez GR, Chwalisz BK, Banik R, Bazin F, Roux M, Cox ED, Taiel M, Sahel JA. Randomized trial of bilateral gene therapy injection for m.11778G?>?A MT-ND4 Leber optic neuropathy. Brain. 2022 Nov 09. PMID: 36350566.
      Citations:    
    9. Covey TJ, Golan D, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Sergott R, Wilken J, Sima DM, Van Hecke W, Gudesblatt M. Individual differences in visual evoked potential latency are associated with variance in brain tissue volume in people with multiple sclerosis: An analysis of brain function-structure correlates. Mult Scler Relat Disord. 2022 Dec; 68:104116. PMID: 36041331.
      Citations:    
    10. Covey TJ, Golan D, Doniger GM, Sergott R, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Mebrahtu S, Bergmann C, Wilken J, Gudesblatt M. Prolonged visual evoked potential latency predicts longitudinal worsening of fatigue in people with multiple sclerosis. Mult Scler Relat Disord. 2022 Nov; 67:104073. PMID: 35964554.
      Citations:    
    11. Covey TJ, Golan D, Doniger GM, Sergott R, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Mebrahtu S, Bergmann C, Wilken J, Gudesblatt M. Longitudinal assessment of the relationship between visual evoked potentials and cognitive performance in multiple sclerosis. Clin Neurophysiol. 2022 05; 137:66-74. PMID: 35279530.
      Citations:    
    12. Maciel CB, Teixeira FJP, Dickinson KJ, Spana JC, Merck LH, Rabinstein AA, Sergott R, Shan G, Miao G, Peloquin CA, Busl KM, Hirsch LJ. Early vigabatrin augmenting GABA-ergic pathways in post-anoxic status epilepticus (VIGAB-STAT) phase IIa clinical trial study protocol. Neurol Res Pract. 2022 Jan 24; 4(1):4. PMID: 35067230.
      Citations:    
    13. Sweid A, Daou BJ, Weinberg JH, Starke RM, Sergott RC, Schaefer J, Hauge J, Elizabeth C, Chalouhi N, Gooch MR, Herial N, Zarzour H, Jabbour P, Rosenwasser RH, Tjoumakaris S. In Reply: Experience With Ventriculoperitoneal and Lumboperitoneal Shunting for the Treatment of Idiopathic Intracranial Hypertension: A Single Institution Series. Oper Neurosurg (Hagerstown). 2021 11 15; 21(6):E579-E580. PMID: 34791406.
      Citations:    
    14. Covey TJ, Golan D, Doniger GM, Sergott R, Zarif M, Bumstead B, Buhse M, Kaczmarek O, Mebrahtu S, Bergmann C, Wilken J, Gudesblatt M. The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in people with multiple sclerosis. Mult Scler Relat Disord. 2022 Jan; 57:103349. PMID: 35158458.
      Citations:    
    15. Sahel JA, Newman NJ, Yu-Wai-Man P, Vignal-Clermont C, Carelli V, Biousse V, Moster ML, Sergott R, Klopstock T, Sadun AA, Blouin L, Katz B, Taiel M. Gene Therapies for the Treatment of Leber Hereditary Optic Neuropathy. Int Ophthalmol Clin. 2021 10 01; 61(4):195-208. PMID: 34584057.
      Citations:    
    16. Moster ML, Sergott RC, Newman NJ, Yu-Wai-Man P, Carelli V, Bryan MS, Smits G, Biousse V, Vignal-Clermont C, Klopstock T, Sadun AA, DeBusk AA, Carbonelli M, Hage R, Priglinger S, Karanjia R, Blouin L, Taiel M, Katz B, Sahel JA. Cross-Sectional Analysis of Baseline Visual Parameters in Subjects Recruited Into the RESCUE and REVERSE ND4-LHON Gene Therapy Studies. J Neuroophthalmol. 2021 Sep 01; 41(3):298-308. PMID: 34310464.
      Citations:    
    17. Margolis MS, DeBusk AA, Moster ML, Falardeau JM, Eggenberger ER, Sergott RC, Van Stavern GP. Lumbar Puncture for Diagnosis of Idiopathic Intracranial Hypertension in Typical Patients. J Neuroophthalmol. 2021 Sep 01; 41(3):375-378. PMID: 34369470.
      Citations:    
    18. Biousse V, Newman NJ, Yu-Wai-Man P, Carelli V, Moster ML, Vignal-Clermont C, Klopstock T, Sadun AA, Sergott RC, Hage R, Esposti S, La Morgia C, Priglinger C, Karanja R, Blouin L, Taiel M, Sahel JA. Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study. J Neuroophthalmol. 2021 09 01; 41(3):309-315. PMID: 34415265.
      Citations:    
    19. Newman NJ, Yu-Wai-Man P, Carelli V, Biousse V, Moster ML, Vignal-Clermont C, Sergott RC, Klopstock T, Sadun AA, Girmens JF, La Morgia C, DeBusk AA, Jurkute N, Priglinger C, Karanjia R, Josse C, Salzmann J, Montestruc F, Roux M, Taiel M, Sahel JA. Intravitreal Gene Therapy vs. Natural History in Patients With Leber Hereditary Optic Neuropathy Carrying the m.11778G>A ND4 Mutation: Systematic Review and Indirect Comparison. Front Neurol. 2021; 12:662838. PMID: 34108929.
      Citations:    
    20. Aytulun A, Cruz-Herranz A, Aktas O, Balcer LJ, Balk L, Barboni P, Blanco AA, Calabresi PA, Costello F, Sanchez-Dalmau B, DeBuc DC, Feltgen N, Finger RP, Frederiksen JL, Frohman E, Frohman T, Garway-Heath D, Gabilondo I, Graves JS, Green AJ, Hartung HP, Havla J, Holz FG, Imitola J, Kenney R, Klistorner A, Knier B, Korn T, Kolbe S, Kr?mer J, Lagr?ze WA, Leocani L, Maier O, Mart?nez-Lapiscina EH, Meuth S, Outteryck O, Paul F, Petzold A, Pihl-Jensen G, Preiningerova JL, Rebolleda G, Ringelstein M, Saidha S, Schippling S, Schuman JS, Sergott RC, Toosy A, Villoslada P, Wolf S, Yeh EA, Yu-Wai-Man P, Zimmermann HG, Brandt AU, Albrecht P. APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies. Neurology. 2021 07 13; 97(2):68-79. PMID: 33910937.
      Citations:    
    21. Sweid A, Daou BJ, Weinberg JH, Starke RM, Sergott RC, Schaefer J, Hauge J, Elizabeth C, Chalouhi N, Gooch R, Herial N, Zarzour H, Jabbour P, Rosenwasser RH, Tjoumakaris S. Experience With Ventriculoperitoneal and Lumboperitoneal Shunting for the Treatment of Idiopathic Intracranial Hypertension: A Single Institution Series. Oper Neurosurg (Hagerstown). 2021 Apr 22. PMID: 33885792.
      Citations:    
    22. Covey TJ, Golan D, Doniger GM, Sergott R, Zarif M, Srinivasan J, Bumstead B, Wilken J, Buhse M, Mebrahtu S, Gudesblatt M. Visual evoked potential latency predicts cognitive function in people with multiple sclerosis. J Neurol. 2021 Nov; 268(11):4311-4320. PMID: 33870445.
      Citations:    
    23. Newman NJ, Yu-Wai-Man P, Carelli V, Moster ML, Biousse V, Vignal-Clermont C, Sergott RC, Klopstock T, Sadun AA, Barboni P, DeBusk AA, Girmens JF, Rudolph G, Karanjia R, Taiel M, Blouin L, Smits G, Katz B, Sahel JA. Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset. Ophthalmology. 2021 05; 128(5):649-660. PMID: 33451738.
      Citations:    
    24. Sergott RC, Raji A, Kost J, Sur C, Jackson S, Locco A, Patel A, Furtek C, Mattson B, Egan MF. Retinal Optical Coherence Tomography Metrics Are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy. J Alzheimers Dis. 2021; 79(1):275-287. PMID: 33252075.
      Citations:    
    25. Yu-Wai-Man P, Newman NJ, Carelli V, Moster ML, Biousse V, Sadun AA, Klopstock T, Vignal-Clermont C, Sergott RC, Rudolph G, La Morgia C, Karanjia R, Taiel M, Blouin L, Burgui?re P, Smits G, Chevalier C, Masonson H, Salermo Y, Katz B, Picaud S, Calkins DJ, Sahel JA. Bilateral visual improvement with unilateral gene therapy injection for Leber hereditary optic neuropathy. Sci Transl Med. 2020 12 09; 12(573). PMID: 33298565.
      Citations:    
    26. Sergott RC, Amorelli GM, Baranello G, Barreau E, Beres S, Kane S, Mercuri E, Orazi L, SantaMaria M, Tremolada G, Santarsiero D, Waskowska A, Yashiro S, Denk N, F?rst-Recktenwald S, Gerber M, Gorni K, Jaber B, Jacobsen B, Mueller L, Nave S, Scalco RS, Marzoli SB. Risdiplam treatment has not led to retinal toxicity in patients with spinal muscular atrophy. Ann Clin Transl Neurol. 2021 01; 8(1):54-65. PMID: 33231373.
      Citations:    
    27. Wu CM, Dunn JP, Sergott RC. Papillitis with retinal venous congestion and intraocular inflammation. Am J Ophthalmol Case Rep. 2020 Dec; 20:100913. PMID: 32984653.
      Citations:    
    28. Watson RA, Wellings J, Hingorani R, Zhan T, Frisch DR, Ho RT, Pavri BB, Sergott RC, Greenspon AJ. Atrial fibrillation post central retinal artery occlusion:role of implantable loop recorders. Pacing Clin Electrophysiol. 2020 Jun 21. PMID: 32567072.
      Citations:    
    29. Daou BJ, Sweid A, Weinberg JH, Starke RM, Sergott RC, Doermann AS, Hauge J, Zanaty M, Chalouhi N, Gooch R, Herial N, Zarzour H, Jabbour P, Rosenwasser RH, Tjoumakaris S. Effect of Shunting on Visual Outcomes and Headache in Patients with Idiopathic Intracranial Hypertension. World Neurosurg. 2020 May 28. PMID: 32474095.
      Citations:    
    30. Scannell Bryan M, Sergott RC. Change in visual acuity and retinal structures following Repository Corticotropin Injection (RCI) therapy in patients with acute demyelinating optic neuritis: Improvement in low contrast visual acuity in both affected and contralateral eyes in a single-armed open-label study. J Neurol Sci. 2019 Dec 15; 407:116505. PMID: 31706456.
      Citations:    
    31. Ackert J, Mohamed K, Slakter JS, El-Harazi S, Berni A, Gevorkyan H, Hardaker E, Hussaini A, Jones SW, Koh GCKW, Patel J, Rasmussen S, Kelly DS, Bara?ano DE, Thompson JT, Warren KA, Sergott RC, Tonkyn J, Wolstenholme A, Coleman H, Yuan A, Duparc S, Green JA. Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers. Drug Saf. 2019 09; 42(9):1103-1114. PMID: 31187437.
      Citations:    
    32. Ross AG, Jivraj I, Rodriguez G, Pistilli M, Chen JJ, Sergott RC, Moster M, Sheldon CA, Liu GT, Foroozan R, Ko MW, Francis CE, Williams ZR, Lee AG, McClelland CM, Shindler KS, Yalamanchili S, Osborne B, Hedges TR, Van Stavern GP, Puckett E, Rigi M, Garc?a-Basterra I, Tamhankar MA. Retrospective, Multicenter Comparison of the Clinical Presentation of Patients Presenting With Diplopia From Giant Cell Arteritis vs Other Causes. J Neuroophthalmol. 2019 Mar; 39(1):8-13. PMID: 29697441.
      Citations:    
    33. Bilyk JR, Murchison AP, Leiby BT, Sergott RC, Eagle RC, Needleman L, Savino PJ. The Utility of Color Duplex Ultrasonography in the Diagnosis of Giant Cell Arteritis: A Prospective, Masked Study. (An American Ophthalmological Society Thesis). Trans Am Ophthalmol Soc. 2017 Aug; 115:T9. PMID: 29967570.
      Citations:    
    34. Birch DG, Benz MS, Miller DM, Antoszyk AN, Markoff J, Kozma P, Meunier E, Sergott RC. EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy. Retina. 2018 Feb; 38(2):364-378. PMID: 28198785.
      Citations:    
    35. Moster ML, Sergott RC, Leiby BE. Dalfampridine Treatment in Nonarteritic Anterior Ischemic Optic Neuropathy. J Neuroophthalmol. 2017 09; 37(3):348-349. PMID: 28538037.
      Citations:    
    36. Finklea BD, Cohen MN, Sergott RC. Severe Headache and Blurred Vision. JAMA Ophthalmol. 2016 10 01; 134(10):1191-1192. PMID: 27533345.
      Citations:    
    37. Srinivasan A, Biro NG, Murchison AP, Sergott RC, Moster ML, Jabbour PM, Bilyk JR. Efficacy of Orbital Color Doppler Imaging and Neuroimaging in the Diagnosis of Carotid Cavernous Fistulas. Ophthal Plast Reconstr Surg. 2016 Sep 06. PMID: 27608286.
      Citations:    
    38. Sergott RC, Johnson CA, Laxer KD, Wechsler RT, Cherny K, Whittle J, Feng G, Lee D, Isojarvi J. Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizures. Epilepsia. 2016 Oct; 57(10):1634-1642. PMID: 27580566.
      Citations:    
    39. Moster SJ, Moster ML, Scannell Bryan M, Sergott RC. Retinal Ganglion Cell and Inner Plexiform Layer Loss Correlate with Visual Acuity Loss in LHON: A Longitudinal, Segmentation OCT Analysis. Invest Ophthalmol Vis Sci. 2016 Jul 01; 57(8):3872-83. PMID: 27459664.
      Citations:    
    40. Pellock JM, Faught E, Foroozan R, Sergott RC, Shields WD, Ziemann A, Lee D, Dribinsky Y, Torri S, Othman F, Isojarvi J. Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry. Epilepsy Behav. 2016 07; 60:174-180. PMID: 27208827.
      Citations:    
    41. Krauss G, Faught E, Foroozan R, Pellock JM, Sergott RC, Shields WD, Ziemann A, Dribinsky Y, Lee D, Torri S, Othman F, Isojarvi J. Sabril? registry 5-year results: Characteristics of adult patients treated with vigabatrin. Epilepsy Behav. 2016 Mar; 56:15-9. PMID: 26807550.
      Citations:    
    42. Kaiser PK, Kampik A, Kuppermann BD, Girach A, Rizzo S, Sergott RC. Safety profile of ocriplasmin for the pharmacologic treatment of symptomatic vitreomacular adhesion/traction. Retina. 2015 Jun; 35(6):1111-27. PMID: 25635577.
      Citations:    
    43. Chen X, Rahimy E, Sergott RC, Nunes RP, Souza EC, Choudhry N, Cutler NE, Houston SK, Munk MR, Fawzi AA, Mehta S, Hubschman JP, Ho AC, Sarraf D. Spectrum of Retinal Vascular Diseases Associated With Paracentral Acute Middle Maculopathy. Am J Ophthalmol. 2015 Jul; 160(1):26-34.e1. PMID: 25849522.
      Citations:    
    44. Sergott RC, Bennett JL, Rieckmann P, Montalban X, Mikol D, Freudensprung U, Plitz T, van Beek J. ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis. J Neurol Sci. 2015 Apr 15; 351(1-2):174-178. PMID: 25758472.
      Citations:    
    45. Brady CJ, Villanti AC, Gupta OP, Graham MG, Sergott RC. Tele-ophthalmology Screening for Proliferative Diabetic Retinopathy in Urban Primary Care Offices: An Economic Analysis. Ophthalmic Surg Lasers Imaging Retina. 2014 Nov 1; 45(6):556-61. PMID: 25423636.
      Citations:    
    46. Bennett JL, Nickerson M, Costello F, Sergott RC, Calkwood JC, Galetta SL, Balcer LJ, Markowitz CE, Vartanian T, Morrow M, Moster ML, Taylor AW, Pace TW, Frohman T, Frohman EM. Re-evaluating the treatment of acute optic neuritis. J Neurol Neurosurg Psychiatry. 2015 Jul; 86(7):799-808. PMID: 25355373.
      Citations:    
    47. Sergott RC, Balcer LJ. The latest on optical coherence tomography. J Neuroophthalmol. 2014 Sep; 34 Suppl:S1-2. PMID: 25133964.
      Citations:    
    48. Sergott RC. Retinal segmentation using multicolor laser imaging. J Neuroophthalmol. 2014 Sep; 34 Suppl:S24-8. PMID: 25133967.
      Citations:    
    49. Adam MK, Krespan K, Moster ML, Sergott RC. Simultaneous, Bilateral Ophthalmoplegia as the Presenting Sign of Paediatric Multiple Sclerosis: Case Report and Discussion of the Differential Diagnosis. Neuroophthalmology. 2014; 38(4):230-237. PMID: 27928305.
      Citations:    
    50. Williams AL, Lackey J, Wizov SS, Chia TM, Gatla S, Moster ML, Sergott R, Spaeth GL, Lai S. Evidence for widespread structural brain changes in glaucoma: a preliminary voxel-based MRI study. Invest Ophthalmol Vis Sci. 2013 Aug 28; 54(8):5880-7. PMID: 23838767.
      Citations:    
    51. Kisza K, Murchison AP, Dai Y, Bilyk JR, Eagle RC, Sergott R, Savino PJ. Giant cell arteritis incidence: analysis by season and year in mid-Atlantic United States. Clin Exp Ophthalmol. 2013 Aug; 41(6):577-81. PMID: 23332080.
      Citations:    
    52. Shen X, Andrews DW, Sergott RC, Evans JJ, Curran WJ, Machtay M, Fragoso R, Eldredge H, Champ CE, Witek M, Mishra MV, Dicker AP, Werner-Wasik M. Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study. Radiat Oncol. 2012; 7:225. PMID: 23270432.
      Citations:    
    53. Huggins A, Sergott RC. Gilenya safety update: cardiac and macula. Curr Opin Ophthalmol. 2012 Nov; 23(6):457-9. PMID: 23047163.
      Citations:    
    54. Sergott RC. Headaches associated with papilledema. Curr Pain Headache Rep. 2012 Aug; 16(4):354-8. PMID: 22669513.
      Citations:    
    55. Murchison AP, Gilbert ME, Bilyk JR, Eagle RC, Pueyo V, Sergott RC, Savino PJ. Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Am J Ophthalmol. 2012 Oct; 154(4):722-9. PMID: 22809782.
      Citations:    
    56. Peterson JD, Bilyk JR, Sergott RC. But it's not all there. Surv Ophthalmol. 2013 Sep-Oct; 58(5):492-9. PMID: 22784676.
      Citations:    
    57. Boland T, Strause J, Hu M, Santamaria D, Liang TW, Kremens D, Sergott R, Moussouttas M. Posterior Reversible Encephalopathy Syndrome Presenting as Opsoclonus-Myoclonus. Neuroophthalmology. 2012 Oct; 36(4):149-152. PMID: 23125471.
      Citations:    
    58. Fecarotta C, Sergott RC. Vigabatrin-associated visual field loss. Int Ophthalmol Clin. 2012; 52(3):87-94, xii. PMID: 22668542.
      Citations:    
    59. Huggins A, Sergott RC. Background and rationale for mechanism of action, efficacy, and safety of fingolimod (Gilenya), the first oral therapy for remitting-relapsing multiple sclerosis: with special emphasis upon visual safety. Curr Opin Ophthalmol. 2011 Nov; 22(6):447-50. PMID: 21946305.
      Citations:    
    60. Pellock JM, Faught E, Sergott RC, Shields WD, Burkhart GA, Krauss GL, Foroozan R, Wesche DL, Weinberg MA. Registry initiated to characterize vision loss associated with vigabatrin therapy. Epilepsy Behav. 2011 Dec; 22(4):710-7. PMID: 21978471.
      Citations:    
    61. Sergott RC. Recommendations for visual evaluations of patients treated with vigabatrin. Curr Opin Ophthalmol. 2010 Nov; 21(6):442-6. PMID: 20811279.
      Citations:    
    62. Sergott RC, Bittman RM, Christen EM, Sagar SM. Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy. Epilepsy Res. 2010 Dec; 92(2-3):170-6. PMID: 20951555.
      Citations:    
    63. Cavallazzi R, Hirani A, Vasu TS, Sergott RC, Bilyk JR, Eagle RC, Weibel S. Clinical manifestations and treatment of adult-onset asthma and periocular xanthogranuloma. Can Respir J. 2009 Sep-Oct; 16(5):159-62. PMID: 19851534.
      Citations:    
    64. Spain RI, Maltenfort M, Sergott RC, Leist TP. Thickness of retinal nerve fiber layer correlates with disease duration in parallel with corticospinal tract dysfunction in untreated multiple sclerosis. J Rehabil Res Dev. 2009; 46(5):633-42. PMID: 19882496.
      Citations:    
    65. Frohman EM, Costello F, St?ve O, Calabresi P, Miller DH, Hickman SJ, Sergott R, Conger A, Salter A, Krumwiede KH, Frohman TC, Balcer L, Zivadinov R. Modeling axonal degeneration within the anterior visual system: implications for demonstrating neuroprotection in multiple sclerosis. Arch Neurol. 2008 Jan; 65(1):26-35. PMID: 18195137.
      Citations:    
    66. Sergott RC, Frohman E, Glanzman R, Al-Sabbagh A. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci. 2007 Dec 15; 263(1-2):3-14. PMID: 17673257.
      Citations:    
    67. Gilbert ME, Sergott RC. New directions in optic neuritis and multiple sclerosis. Curr Neurol Neurosci Rep. 2007 May; 7(3):259-64. PMID: 17488593.
      Citations:    
    68. Sergott RC. Historical perspective and future prospective for retinal nerve fiber loss in optic neuritis and multiple sclerosis. Int Ophthalmol Clin. 2007; 47(4):15-24, x. PMID: 18049278.
      Citations:    
    69. Gilbert ME, Sergott RC. Intracranial aneurysms. Curr Opin Ophthalmol. 2006 Dec; 17(6):513-8. PMID: 17065918.
      Citations:    
    70. Lin A, Foroozan R, Danesh-Meyer HV, De Salvo G, Savino PJ, Sergott RC. Occurrence of cerebral venous sinus thrombosis in patients with presumed idiopathic intracranial hypertension. Ophthalmology. 2006 Dec; 113(12):2281-4. PMID: 17157135.
      Citations:    
    71. Rebolleda G, Mu?oz-Negrete FJ, Noval S, Contreras I, Gilbert ME, Sergott RC. New ways to look at an old problem. Surv Ophthalmol. 2006 Mar-Apr; 51(2):169-73. PMID: 16500217.
      Citations:    
    72. Piette SD, Sergott RC. Pathological optic-disc cupping. Curr Opin Ophthalmol. 2006 Feb; 17(1):1-6. PMID: 16436917.
      Citations:    
    73. Mathews MK, Frohman L, Lee HJ, Sergott RC, Savino PJ. Spinal fluid leak after chiropractic manipulation of the cervical spine. Arch Ophthalmol. 2006 Feb; 124(2):283. PMID: 16476904.
      Citations:    
    74. Sylvester CL, Drohan LA, Sergott RC. Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1. Curr Opin Ophthalmol. 2006 Feb; 17(1):7-11. PMID: 16436918.
      Citations:    
    75. Foroozan R, Buono LM, Sergott RC, Kawasaki A. Jumping Jack Flash. Surv Ophthalmol. 2006 Jan-Feb; 51(1):63-7. PMID: 16414362.
      Citations:    
    76. Sergott RC. Neuro-ophthalmology does have a future. Curr Opin Ophthalmol. 2005 Dec; 16(6):333. PMID: 16264341.
      Citations:    
    77. Sergott RC. Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis. Curr Opin Ophthalmol. 2005 Dec; 16(6):346-50. PMID: 16264344.
      Citations:    
    78. Behbehani RS, Vacarezza N, Sergott RC, Bilyk JR, Hochberg F, Savino PJ. Isolated optic nerve lymphoma diagnosed by optic nerve biopsy. Am J Ophthalmol. 2005 Jun; 139(6):1128-30. PMID: 15953457.
      Citations:    
    79. Behbehani R, Sergott RC, Frohman L. Foggy vision. Surv Ophthalmol. 2005 May-Jun; 50(3):285-9. PMID: 15850817.
      Citations:    
    80. Danesh-Meyer HV, Savino PJ, Bilyk JR, Sergott RC. Aggressive glioma of adulthood simulating ischemic optic neuropathy. Arch Ophthalmol. 2005 May; 123(5):694-700. PMID: 15883294.
      Citations:    
    81. Behbehani R, Mathews MK, Sergott RC, Savino PJ. Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol. 2005 Mar; 139(3):518-21. PMID: 15767063.
      Citations:    
    82. Behbehani R, Sergott RC, Savino PJ. The antiphospholipid antibody syndrome: diagnostic aspects. Curr Opin Ophthalmol. 2004 Dec; 15(6):483-5. PMID: 15523192.
      Citations:    
    83. Behbehani R, Sergott RC, Savino PJ. Orbital radiotherapy for thyroid-related orbitopathy. Curr Opin Ophthalmol. 2004 Dec; 15(6):479-82. PMID: 15523191.
      Citations:    
    84. Danesh-Meyer HV, Savino PJ, Sergott RC. Visual loss despite anticoagulation in radiation-induced optic neuropathy. Clin Exp Ophthalmol. 2004 Jun; 32(3):333-5. PMID: 15180850.
      Citations:    
    85. Castillo IG, Reinecke RD, Sergott RC, Wizov S. Surgical treatment of trauma-induced periodic alternating nystagmus. Ophthalmology. 2004 Jan; 111(1):180-3. PMID: 14711732.
      Citations:    
    86. Mathews MK, Sergott RC, Savino PJ. Pseudotumor cerebri. Curr Opin Ophthalmol. 2003 Dec; 14(6):364-70. PMID: 14615641.
      Citations:    
    87. Buono LM, Foroozan R, Sergott RC. Unexplained visual loss. Surv Ophthalmol. 2003 Nov-Dec; 48(6):626-30. PMID: 14609708.
      Citations:    
    88. Deramo VA, Sergott RC, Augsburger JJ, Foroozan R, Savino PJ, Leone A. Ischemic optic neuropathy as the first manifestation of elevated cholesterol levels in young patients. Ophthalmology. 2003 May; 110(5):1041-6; discussion 1046. PMID: 12750110.
      Citations:    
    89. Foroozan R, Buono LM, Savino PJ, Sergott RC. Scanning laser polarimetry of the retinal nerve fiber layer in central retinal artery occlusion. Ophthalmology. 2003 Apr; 110(4):715-8. PMID: 12689892.
      Citations:    
    90. Foroozan R, Deramo VA, Buono LM, Jayamanne DG, Sergott RC, Danesh-Meyer H, Savino PJ. Recovery of visual function in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2003 Mar; 110(3):539-42. PMID: 12623817.
      Citations:    
    91. Maust HA, Foroozan R, Sergott RC, Niazi S, Weibel S, Savino PJ. Use of methotrexate in sarcoid-associated optic neuropathy. Ophthalmology. 2003 Mar; 110(3):559-63. PMID: 12623821.
      Citations:    
    92. Buono LM, Foroozan R, Sergott RC, Savino PJ. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2002 Dec; 13(6):357-61. PMID: 12441837.
      Citations:    
    93. Foroozan R, Buono LM, Savino PJ, Sergott RC. Acute demyelinating optic neuritis. Curr Opin Ophthalmol. 2002 Dec; 13(6):375-80. PMID: 12441840.
      Citations:    
    94. Buono LM, Foroozan R, Sergott RC, Savino PJ. Is normal tension glaucoma actually an unrecognized hereditary optic neuropathy? New evidence from genetic analysis. Curr Opin Ophthalmol. 2002 Dec; 13(6):362-70. PMID: 12441838.
      Citations:    
    95. Andrews DW, Faroozan R, Yang BP, Hudes RS, Werner-Wasik M, Kim SM, Sergott RC, Savino PJ, Shields J, Shields C, Downes MB, Simeone FA, Goldman HW, Curran WJ. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery. 2002 Oct; 51(4):890-902; discussion 903-4. PMID: 12234395.
      Citations:    
    96. Castillo IG, Foroozan R, Sergott RC. A sticky situation. Surv Ophthalmol. 2002 Sep-Oct; 47(5):491-9. PMID: 12431696.
      Citations:    
    97. Foroozan R, Danesh-Meyer H, Savino PJ, Gamble G, Mekari-Sabbagh ON, Sergott RC. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology. 2002 Jul; 109(7):1267-71. PMID: 12093648.
      Citations:    
    98. Foroozan R, Buono LM, Sergott RC, Savino PJ. Retrobulbar optic neuritis associated with infliximab. Arch Ophthalmol. 2002 Jul; 120(7):985-7. PMID: 12096976.
      Citations:    
    99. Foroozan R, Savino PJ, Sergott RC. Embolic central retinal artery occlusion detected by orbital color Doppler imaging. Ophthalmology. 2002 Apr; 109(4):744-7; discussion 747-8. PMID: 11927432.
      Citations:    
    Sergott's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (294)
    Explore
    _
    Co-Authors (36)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _